Teriparatide -: rhPTH(1-34) -: LY-333334 -: Forteo® -: Treatment of osteoporosis -: Parathyroid hormone

被引：0
|
作者：
不详
机构：
来源：
DRUGS OF THE FUTURE | 2001年 / 26卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：824 / 827
页数：4
相关论文
共 50 条
  • [41] Effect of teriparatide [rhPTH(1-34)] on BMD when given to postmenopausal women receiving hormone replacement therapy
    Ste-Marie, LG
    Schwartz, SL
    Hossain, A
    Desaiah, D
    Gaich, GA
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 (02) : 283 - 291
  • [42] TeriparatideLY 333334, MN 10T, Parathyroid Hormone (1–34), Parathyroid Hormone (1–34) — Asahi, Parathyroid Hormone (1–34) — Eli Lilly, Parathyroid Hormone (1–34) — Rhône-Poulenc Rorer, Teriparatide Acetate, hPTH 1–34, Parathar®
    [J]. Drugs in R & D, 1999, 1 (3) : 222 - 224
  • [43] Distinctive effects of teriparatide [rhPTH(1-34)] and alendronate on bone turnover and lumbar spine bone density in women with osteoporosis
    McClung, MR
    Miller, PD
    Civitelli, R
    Warren, ML
    Greenspan, SL
    Tamayo, JA
    Donley, DW
    San Martin, J
    [J]. OSTEOPOROSIS INTERNATIONAL, 2002, 13 : S18 - S18
  • [44] Nonuremic calciphylaxis precipitated by teriparatide [rhPTH(1-34)] therapy in the setting of chronic warfarin and glucocorticoid treatment
    Spanakis, E. K.
    Sellmeyer, D. E.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2014, 25 (04) : 1411 - 1414
  • [45] Effects of teriparatide [rhPTH (1-34)] treatment on structural geometry of the proximal femur in elderly osteoporotic women
    Uusi-Rasi, K
    Semanick, LM
    Zanchetta, JR
    Bogado, CE
    Eriksen, EF
    Sato, M
    Beck, TJ
    [J]. BONE, 2005, 36 (06) : 948 - 958
  • [46] Continuous rhPTH (1-34) treatment in chronic hypoparathyroidism
    Fuss, Carmina Teresa
    Burger-Stritt, Stephanie
    Horn, Silke
    Koschker, Ann-Cathrin
    Frey, Kathrin
    Meyer, Almuth
    Hahner, Stefanie
    [J]. ENDOCRINOLOGY DIABETES AND METABOLISM CASE REPORTS, 2020, : 1 - 6
  • [47] Parathyroid hormone (1-84) and teriparatide in the treatment of postmenopausal osteoporosis
    Bogado, Cesar E.
    Massari, Fabio E.
    Zanchetta, Jose R
    [J]. WOMENS HEALTH, 2006, 2 (03) : 447 - 457
  • [48] Assessment of effects of LY333334 [recombinant human parathyroid hormone (1-34)] on cortical bone using digital X-ray radiogrammetry.
    Hyldstrup, L
    Jorgensen, JT
    Gaich, G
    [J]. BONE, 2001, 28 (05) : S97 - S98
  • [49] Parathyroid Hormone (1-34)-Coated Microneedle Patch System: Clinical Pharmacokinetics and Pharmacodynamics for Treatment of Osteoporosis
    Daddona, Peter E.
    Matriano, James. A.
    Mandema, Jaap
    Maa, Yuh-Fun
    [J]. PHARMACEUTICAL RESEARCH, 2011, 28 (01) : 159 - 165
  • [50] Pharmacokinetics of Teriparatide (rhPTH[1–34]) and Calcium Pharmacodynamics in Postmenopausal Women with Osteoporosis
    Julie Satterwhite
    Michael Heathman
    Paul D. Miller
    Fernando Marín
    Emmett V. Glass
    Harald Dobnig
    [J]. Calcified Tissue International, 2010, 87 : 485 - 492
12345